Yan Shang
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine 7
- Aging top 2%
- Molecular Medicine top 2%
- Physiology top 5%
- Asthma and respiratory diseases 6
- Adipose Tissue and Metabolism 4
- Hematology top 5%
- Erythropoietin and Anemia Treatment 8
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
-
- PARP inhibition in cancer therapy 5
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
- Journals
- Current Neurovascular Research (10 papers)Expert Opinion on Therapeutic Targets (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yan Shang
68 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 142
- Geriatrics and Gerontology 381
- Aging 118
- Molecular Medicine 186
- Physiology 104
- Hematology 245
Countries citing papers authored by Yan Shang
This map shows the geographic impact of Yan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shang more than expected).
Fields of papers citing papers by Yan Shang
This network shows the impact of papers produced by Yan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shang. The network helps show where Yan Shang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 1 | |
| 15 | 2016 | 96 | |
| 16 | 2014 | 6 | |
| 17 | 2013 | 35 | |
| 18 | 2012 | 2 | |
| 19 | 2012 | 6 | |
| 20 | 2009 | 49 |
About Yan Shang
Yan Shang is a scholar working on Geriatrics and Gerontology, Microbiology and Hematology, having authored 74 papers that have together received 2.4k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (8 papers), Sirtuins and Resveratrol in Medicine (7 papers), Asthma and respiratory diseases (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), PARP inhibition in cancer therapy (5 papers), Circular RNAs in diseases (5 papers), Adipose Tissue and Metabolism (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Geriatrics and Gerontology (381 citations), Aging (118 citations) and Molecular Medicine (186 citations). Yan Shang has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhao Zhong Chong, Kenneth Maiese, Jinling Hou, Shaohui Wang, Yan Wang, Fan Qiao, Hai Jin, Yunye Ning, Chong Bai and Wan‐Yee Tang. Their work appears in journals such as Current Neurovascular Research, Expert Opinion on Therapeutic Targets, Oxidative Medicine and Cellular Longevity, Journal of Asthma and Frontiers in Sustainable Food Systems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.